JPMorgan Upgrades Pacific Biosciences of California (PACB) to Neutral
Get Alerts PACB Hot Sheet
Price: $3.86 +3.76%
Rating Summary:
12 Buy, 8 Hold, 0 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Rating Summary:
12 Buy, 8 Hold, 0 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE
JPMorgan upgraded Pacific Biosciences of California (NASDAQ: PACB) from Underweight to Neutral with a price target of $7.00 (unchanged)
For an analyst ratings summary and ratings history on Pacific Biosciences of California click here. For more ratings news on Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $4.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Estee Lauder (EL) to Buy; 'Earnings have bottomed'
- HSBC Upgrades Scor SE (SCR:FP) (SCRYY) to Buy, 'cheapest way to play the positive dynamics in reinsurance'
- Evercore ISI Upgrades Kimberly Clark (KMB) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!